Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating isomiRs May Be Superior Biomarkers Compared to Their Corresponding miRNAs: A Pilot Biomarker Study of Using isomiR-Ome to Detect Coronary Calcium-Based Cardiovascular Risk in Patients with NAFLD.
Makarenkov N, Yoel U, Haim Y, Pincu Y, Bhandarkar NS, Shalev A, Shelef I, Liberty IF, Ben-Arie G, Yardeni D, Rudich A, Etzion O, Veksler-Lublinsky I. Makarenkov N, et al. Among authors: yardeni d. Int J Mol Sci. 2024 Jan 10;25(2):890. doi: 10.3390/ijms25020890. Int J Mol Sci. 2024. PMID: 38255963 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Bulevirtide for HBV and HDV infections.
Yardeni D, Koh C. Yardeni D, et al. Drugs Today (Barc). 2021 Jul;57(7):433-448. doi: 10.1358/dot.2021.57.7.3283861. Drugs Today (Barc). 2021. PMID: 34268531
Chronic hepatitis D-What is changing?
Yardeni D, Heller T, Koh C. Yardeni D, et al. J Viral Hepat. 2022 Apr;29(4):240-251. doi: 10.1111/jvh.13651. Epub 2022 Feb 19. J Viral Hepat. 2022. PMID: 35122369 Review.
Impact of Proteinuria on Liver Enzyme Levels.
Yardeni D, Hitawala A, Howard L, Heller T, Waldman M. Yardeni D, et al. J Clin Transl Hepatol. 2024 Sep 28;12(9):759-760. doi: 10.14218/JCTH.2024.00169. Epub 2024 Jul 19. J Clin Transl Hepatol. 2024. PMID: 39280066 Free PMC article. No abstract available.
40 results